FDA Gives Aytu OK To Distribute Rapid COVID-19 Test, Company Expects To Receive 100,000 Tests This WeekBenzinga • 03/23/20
The Latest Coronavirus Developments From Biotechs: La Jolla Provides Giapreza In Italy, Enanta Researches AntiviralsBenzinga • 03/13/20
Aytu BioScience, Inc. (AYTU) Shares March Higher, Can It Continue?Zacks Investment Research • 03/11/20
All You Need to Know About Aytu Bioscience, Inc. (AYTU) Rating Upgrade to BuyZacks Investment Research • 02/19/20
Aytu BioScience's (AYTU) CEO Josh Disbrow on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/14/20
Aytu Bioscience, Inc. (AYTU) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseZacks Investment Research • 01/30/20
Aytu BioScience, Inc. (AYTU) CEO Joshua Disbrow on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/15/19
Aytu Bioscience, Inc. (AYTU) Reports Q1 Loss, Lags Revenue EstimatesZacks Investment Research • 11/15/19
Aytu BioScience, Inc. (AYTU) CEO Josh Disbrow on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 09/27/19
Aytu BioScience, Inc. (AYTU) CEO Josh Disbrow on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/14/19
Aytu Bioscience, Inc. (AYTU) Moves to Buy: Rationale Behind the UpgradeZacks Investment Research • 04/11/19
Aytu Bioscience, Inc. (AYTU) Upgraded to Buy: What Does It Mean for the Stock?Zacks Investment Research • 03/11/19